genedrive plc (LON:GDR – Get Free Report)’s stock price was up 4.3% during trading on Wednesday . The stock traded as high as GBX 2.40 ($0.03) and last traded at GBX 2.40 ($0.03). Approximately 1,421,360 shares changed hands during mid-day trading, a decline of 90% from the average daily volume of 14,291,111 shares. The stock had previously closed at GBX 2.30 ($0.03).
genedrive Trading Up 4.3 %
The firm has a market cap of £13.04 million, a P/E ratio of -57.50 and a beta of -0.04. The company has a current ratio of 1.63, a quick ratio of 5.52 and a debt-to-equity ratio of 8.57. The company’s fifty day moving average price is GBX 2.27 and its two-hundred day moving average price is GBX 2.74.
Insider Buying and Selling at genedrive
In other genedrive news, insider Ian David Gilham acquired 1,000,000 shares of genedrive stock in a transaction on Wednesday, August 14th. The shares were bought at an average price of GBX 3 ($0.04) per share, with a total value of £30,000 ($38,905.46). Company insiders own 14.75% of the company’s stock.
About genedrive
genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive system, a rapid thermocycler and signal detection system and semi- automated system used forqualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
Featured Stories
- Five stocks we like better than genedrive
- How to Calculate Inflation Rate
- 3 ETFs With Low Fees and Market-Beating Returns
- What Are Dividend Champions? How to Invest in the Champions
- Inflation Threats Make Yield Curve ETFs a Top Trade
- Technology Stocks Explained: Here’s What to Know About Tech
- Double-Digit Gains Ahead? Top 2 Stocks Positioned to Outperform
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.